Welcome to A Time's Memory Blog

____________________________________

A TIME'S MEMORY - Flu, Bugs & Other Accidents Blog - Year: XIII - Here, Reader, you will find many items if your interests are in the field of emerging threats to global or public health, with a perspective that is not mainstream. Thank to You for the interest!

_______________________________________

16 Oct 2018

#Avian #Influenza [#H7N9, #H5N6, #H5N1] #Report - October 7 – 13 ‘18 (Wk 41) (#HK CHP, Oct. 16 ‘18)

          

Title:

#Avian #Influenza [#H7N9, #H5N6, #H5N1] #Report - October 7 – 13 ‘18 (Wk 41).

Subject:

Influenza A of Avian Origin, H5, H7 & H9 subtypes, global poultry panzootic and human cases in China and worldwide, weekly update.

Source:

Centre for Health Protection (CHP), Hong Kong PRC SAR, full PDF file: (LINK).

Code:

[     |     ]

___

1

__



-

Keywords: HK PRC SAR; Updates; China; Worldwide; Human; Poultry; H5N1; H5N6; H7N9.

-------

One New #MERS #Coronavirus Case reported by #Saudi Arabia (MoH, October 16 '18)

          

Title:

One New MERS Coronavirus Case reported by Saudi Arabia (MoH, October 16 '18).

Subject:

Middle East Respiratory Syndrome in Saudi Arabia, daily update.

Source:

Saudi Arabia Ministry of Health, full PDF file: (LINK).

Code:

[     ]

___

3

__

October 16 2018


New Case(s) Reported:

[Date report - Sex, Age, Citizenship, Resident in, Date Onset, Date Hospitalization, Health Status, Note]

  1. 16/10 – Male, 64, ..., Afeef, ..., ..., Hospitalized; *

__

{*} Primary case (community-acquired; no contact with camels).

___

Cumulative number of confirmed cases and deaths since 2012:

  • Total No. of Cases: 1882 {§}
  • Total No. of Deaths: 729 {§}
  • Patients currently under treatment: ...
  • Case-Fatality Rate: 39%

{§} WHO data as of October 11 2018, see more: http://www.emro.who.int/pandemic-epidemic-diseases/mers-cov/mers-situation-update-september-2018.html

___

-

Keywords: MERS-CoV; Updates; Saudi Arabia.

------

China, Influenza [#H1N1pdm09, #H3N2, B, #H7N9] Weekly #Report - Wk 40 ‘18 (CNIC, Oct. 16 ‘18)

          

Title:

China, Influenza [#H1N1pdm09, #H3N2, B, #H7N9] Weekly #Report - Wk 40 ‘18.

Subject:

Human and Avian Influenza Viruses, A (H1, H3, H7) & B subtypes, current epidemiological situation in China.

Source:

National Influenza Centre, PR of China, full page: (LINK).

Code:

[     ]

___

2

__

Download full document:china flu report 1840.pdf

(All data are preliminary and may change as more reports are received)


Summary

  • During week 40, influenza activity level in mainland China was very low, only a few influenza viruses can be detected, majority were A(H1N1)pdm09.
  • Among influenza viruses antigenically characterized by CNIC since October 1st, 2017:
    • 722(92.6%) influenza A(H1N1)pdm09 viruses were characterized as A/Michigan/45/2015-like;
    • 134(34.7%) influenza A(H3N2) viruses were characterized as A/Hong Kong/4801/2014 (H3N2)(EGG)-like,
    • 351(90.9%) influenza A(H3N2) viruses were characterized as A/Hong Kong/4801/2014 (H3N2)(CELL)-like;
    • 166(59.9%) influenza B/Victoria viruses were characterized as B/Brisbane/60/2008-like;
    • 847(97.5%) influenza B/Yamagata viruses were characterized as B/Phuket/3073/2013-like.
  • Among the influenza viruses tested by CNIC for antiviral resistance analysis since October 1st, 2017:
    • all influenza A(H1N1)pdm09 and A(H3N2) viruses were resistant to amantadine;
    • All influenza A(H3N2) and B viruses were sensitive to neuraminidase inhibitors.
    • All but 4 influenza A(H1N1)pdm09 were sensitive to neuraminidase inhibitors.


Outbreak Surveillance

  • During week 40(October 1st –October 7th , 2018), there was no outbreak reported nationwide.


Surveillance of outpatient or emergency visits for Influenza-like Illness (ILI)

  • During week 40, the percentage of outpatient or emergency visits for ILI (ILI %) at national sentinel hospitals in southern provinces was 3.4%, higher than the last week (2.9%), higher than the same week of 2015 and 2016 (2.7% and 2.9%), lower than the same week of 2017(3.7%). (Figure 1)
  • During week 40, ILI% at national sentinel hospitals in northern provinces was 2.8%, higher than the last week (2.0%) and the same week of 2015 and 2016 (2.5%, 2.6% ) , lower than the same week of 2017 (3.2%). (Figure 2)

___

Figure 1. Percentage of Visits for ILI at Sentinel Hospitals in South China (2015-2019)

W020181016527584874260

__

Figure 2. Percentage of Visits for ILI at Sentinel Hospitals in North China (2015-2019)

W020181016527584887550

__

Virologic Surveillance

  • During week 40, influenza network laboratories tested 6356 specimens, of which 30(0.5%) were positive for influenza, influenza A and influenza B viruses were 25(83.3%) and 5(16.7%), respectively (Table 1).
  • During week 40, the percentage of specimens that were tested positive for influenza in south China was 0.9%, which was slightly lower than the previous week (1.3%) (Figure 3).
  • During week 40, the percentage of specimens that were tested positive for influenza in north China was 0.1%, and there was no specimen tested positive for influenza in the previous week. (Figure 4).


Table 1 Laboratory Detections of ILI Specimens (Week 40, 2018)

[Week 40 - South China - North China – Total]

  • No. of specimens tested – 3327 – 3029 – 6356
    • No. of positive specimens (%) - 29(0.9%) - 1(0.1%) - 30(0.5%)
      • Influenza A - 25(86.2%) - 0(0) - 25(83.3%)
        • A(H3N2) - 3(12.0%) - 0(0) - 3(12.0%)
        • A(H1N1)pdm09 - 22(88.0%) - 0(0) - 22(88.0%)
        • A (subtype not determined) - 0(0) - 0(0) - 0(0)
      • Influenza B - 4(13.8%) - 1(100%) - 5(16.7%)
        • B (lineage not determined) - 0(0) - 0(0) - 0(0)
        • Victoria - 2(50.0%) - 0(0) - 2(40.0%)
        • Yamagata - 2(50.0%) - 1(100%) - 3(60.0%)

___

Figure 3. Influenza Positive Tests Reported by Southern Network Laboratories (Week 14, 2017–Week 40, 2018)

W020181016527584898245

__

Note: Analysis in this part was based on the test results of network laboratories. If it were not consistent with the results of CNIC confirmation, the results of CNIC confirmation were used.

___

Figure 4. Influenza Positive Tests Reported by Northern Network Laboratories (Week 14, 2017–Week 40, 2018)

W020181016527584892785

__

Note: Analysis in this part was based on the result of network laboratories. If it were not consistent with the results of CNIC confirmation, the results of CNIC confirmation were used.

(…)

H7N9 case report

  • Since the notification of human infection with novel reassortant influenza A(H7N9) virus on 31 March 2013, in total 1564 laboratory-confirmed cases have been reported to WHO.
  • Among them, 32 cases were infected with HPAI A(H7N9) virus, which have mutations in the hemagglutin in gene indicating a change to high pathogenicity in poultry.
  • These 32 cases are from Taiwan (the case had travel history to Guangdong), Guangxi, Guangdong, Hunan, Shaanxi, Hebei, Henan, Fujian, Yunnan provinces, with illness onset date before October 2017.
  • No increased transmissibility or virulence to human case was detected in the HPAI A(H7N9) virus.


-

Keywords: China; Updates; Seasonal Influenza; Avian Influenza; H1N1pdm09; H3N2; B; H7N9.

------

#WHO calls #IHR(2005) #EC #Meeting over deadly #Ebola #outbreak in #DRC (UN News Centre, Oct. 16 ‘18)

          

Title:

#WHO calls #IHR(2005) #EC #Meeting over deadly #Ebola #outbreak in #DRC.

Subject:

Ebola Virus Disease Outbreak in the Dem. Rep. of Congo; WHO requested for an IHR(2005) EC Meeting.

Source:

United Nations News Centre, full page: (LINK).

Code:

[     | INTL ]

___

1

__

15 October 2018


World Health Organization (WHO) Director-General, Dr Tedros Adhanom Ghebreyesus, has called an Emergency Committee meeting on the Ebola virus outbreak in the Democratic Republic of the Congo (DRC), which has already claimed around 130 lives.

The WHO has assessed the national and regional risk of the current Ebola outbreak in DRC as “very high,” although the global risk remains low and, so far, the UN’s health watchdog has not called for any trade or travel restrictions to be imposed.

The Emergency Committee, scheduled for Wednesday at WHO headquarters in Geneva, will decide whether the outbreak constitutes a public health emergency of international concern, and what recommendations should be made to manage the spread of the disease.

This outbreak, the tenth to hit the DRC over the last four decades, was declared in North Kivu Province on 1 August, this year and, based on the worsening security situation in and around the city of Beni, WHO elevated the risk from “high” to “very high” on 28 September.

The agency identified 39 new confirmed cases were reported between 1 and 11 October, 32 of which are from Beni.

The DRC Ministry of Health, WHO and other partners have been responding to the outbreak with teams on the ground, but WHO has warned that continuing insecurity severely affects both civilians and frontline workers, forcing the suspension of the response for several days in late September, and raising the risk that the virus will continue to spread.

More than 20 civilians in Beni were killed in the incident that provoked the suspension, which came on the heels of multiple attacks in previous weeks. It’s estimated by the UN that more than a million civilians under threat from armed groups, are internally-displaced in North Kivu; around 500,000 this year alone. The eastern region is close to the border with Uganda, and Rwanda.

Meanwhile, the UN Children’s Fund (UNICEF) reports that one month after the beginning of the school year, 80 per cent of school-aged children have returned to school in Beni and Mabalako health zones, the two epicentres of the Ebola outbreak.  UNICEF has identified more than 1,500 schools in the areas affected by the epidemic.

-

Keywords: UN; WHO; Updates; Ebola; DRC.

------

15 Oct 2018

Low pathogenic #avian #influenza #H7N3, #USA [a #poultry #outbreak in #California] (#OIE, Oct. 15 ‘18)

          

Title:

Low pathogenic #avian #influenza #H7N3, #USA [a #poultry #outbreak in #California].

Subject:

Avian Influenza, H7N3 subtype, poultry epizootics in the US.

Source:

OIE, full page: (LINK).

Code:

[     ]

___

3
__


Information received on 12/10/2018 from Dr John Clifford, Official Delegate, Chief Trade Advisor, Animal and Plant Health Inspection Service, United States Department of Agriculture, Washington, United States of America

  • Summary
    • Report type    Follow-up report No. 3
    • Date of start of the event    06/09/2018
    • Date of confirmation of the event    08/09/2018
    • Report date    12/10/2018
    • Date submitted to OIE    12/10/2018
    • Reason for notification    Recurrence of a listed disease
    • Date of previous occurrence    30/04/2018
    • Manifestation of disease    Clinical disease
    • Causal agent    Low pathogenic avian influenza virus
    • Serotype    H7N3
    • Nature of diagnosis    Laboratory (advanced)
    • This event pertains to    a defined zone within the country
  • Summary of outbreaks   
    • Total outbreaks: 1
      • Total animals affected: Species    - Susceptible    - Cases    - Deaths    - Killed and disposed of    - Slaughtered
        • Birds    - 33400    - … – … – … – …**           
      • Outbreak statistics: Species    - Apparent morbidity rate    - Apparent mortality rate    - Apparent case fatality rate    - Proportion susceptible animals lost*
        • Birds    - **    - **    - **    - **
          • *Removed from the susceptible population through death, destruction and/or slaughter
          • **Not calculated because of missing information
  • Epidemiology
    • Source of the outbreak(s) or origin of infection   
      • Unknown or inconclusive
  • Epidemiological comments   
    • As part of the pre-slaughter testing and surveillance program for H5/H7 Avian Influenza, H7N3 low pathogenic avian influenza (LPAI) was detected in a commercial meat-type turkey flock.
    • Partial HA /NA sequencing determined the H7 and N3 to be a low pathogenic virus of North American wild bird lineage.
    • A comprehensive epidemiological investigation with enhanced surveillance is ongoing.
    • State officials have quarantined the affected premises and implemented movement controls.
    • Partial sequencing is consistent with LPAI North American wild bird lineage, and partial fragments of subsequent samples collected are 100% similar to index case.
    • Further characterization is pending virus recovery.

(...)
___

-

Keywords: OIE; Updates; Avian Influenza; H7N3 ; Poultry; USA; California.

------

#Chikungunya – #Sudan (@WHO, October 15 2018)

          

Title:

#Chikungunya – #Sudan.

Subject:

Chikungunya Fever Outbreak in Sudan, current situation.

Source:

World Health Organization (WHO), full page: (LINK).

Code:

[     ]

___

2

__

Disease outbreak news | 15 October 2018


On 31 May 2018, the State Ministry of Health (SMOH) of the Red Sea State in Sudan reported four suspected cases of chikungunya fever from Swakin locality, in Red Sea State. Among the signs and symptoms were sudden onset of fever, headache, joint pain and swelling, muscle pain and/or inability to walk.

The first suspected case of chikungunya in the neighboring Kassala State was reported on 8 August 2018, in a male travelling from the Red Sea State.

Since then cases have been reported in three localities of the State (Kassala, West Kassala and Rural Kassala).

On 10 August, among 24 collected blood samples, 22 samples tested positive for chikungunya by PCR and ELISA at the National Public Health Laboratory (NPHL) in Khartoum.

On 9 September, an additional 100 samples were collected and pooled in batches of ten: 50% of pools tested positive for mixed chikungunya and dengue viruses, and all pools were positive for chikungunya virus.

From 31 May through 2 October 2018, seven States (Kassala, Red Sea, Al Gadaref, River Nile, Northern State, South Darfur, and Khartoum) have been affected with a total of 13 978 cases of chikungunya, 95% of which are from Kassala State.

No hospital admission or death has been officially reported.

Approximately 7% of the reported cases were children less than 5 years of age and 60% were females.


Public health response

  • Federal Ministry of Health (FMOH) and the Health Cluster organized an ad-hoc Health Cluster Coordination meeting to engage health cluster partners in addressing the current outbreak.
  • FMOH in collaboration with WHO and partners prepared an accelerated response plan to scale up vector control and health education campaigns.
  • Volunteers were mobilized to conduct house-to-house visits, inspection and targeted health education campaigns.
  • WHO technically and financially supported the surveillance system and case management.
  • WHO and partners provided logistical and financial support to the response operation (case management, surveillance, vector control, health education and risk communication) in affected localities in Kassala, Gadaref and Red Sea States.
  • WHO mobilized funds to support the scaled up operations by the FMOH including deployment of various staff at both the Federal and State level.


WHO risk assessment

The overall risk of chikungunya at the national level is very high because of the following: presence of Aedes aegypti in most parts of the country, availability of breeding sites in houses and uncoordinated community involvement in vector control aggravated by the ongoing rainy season which favours the proliferation of the vector and spread of the outbreak to other states in the country.

Also, in the absence of a good surveillance system to clearly define the dynamics of the outbreak, it is a big challenge to target the public health actions to control the outbreak.

The lack of financial and technical resources to respond to needs, if not addressed immediately and properly, may lead to further escalation of the number of cases and eventually overwhelm the already over-stretched capacities of the country.

The risk at the regional level is considered moderate.

WHO Regional Office is already mobilizing its resources to support the ongoing outbreak and is prepared to support other neighbouring countries if the outbreak spreads outside Sudan.

The overall risk at the global level is low.


WHO advice

Prevention and control of chikungunya relies heavily on reducing the number of natural and artificial water-filled container habitats that support breeding of the mosquitoes. This requires mobilization of affected communities. During outbreaks, insecticides may be sprayed to kill mosquitoes, applied to surfaces in and around containers where the mosquitoes land, and used to treat water in containers to kill the immature larvae.

For protection during outbreaks of chikungunya, clothing which minimizes skin exposure to the day-biting vectors is advised. Repellents can be applied to exposed skin or to clothing in strict accordance with product label instructions. For those who sleep during the daytime, insecticide-treated mosquito nets afford good protection.

Basic precautions should be taken by people travelling to risk areas and these include use of repellents, wearing long sleeves and pants and ensuring rooms are fitted with screens to prevent mosquitoes from entering.

For more information, please see the link below:

-

Keywords: WHO; Updates; Chikungunya Fever; Sudan.

------

#Influenza A of #Animal Origin, #Human #Infections – #Worldwide, October 15 ‘18 #Update (@WHO, edited)

          

Title:

Subject:

Influenza A of Animal Origin, H1, H3, H5, H7 & H9 subtypes, current global epidemiological situation, monthly update.

Source:

World Health Organization (WHO), full PDF file: (LINK).

Code:

[     ]

___

1

__


-

Keywords: WHO; Updates; Worldwide; Avian Influenza; Swine Influenza; Human; H1N2; H5N6; H7N9.

------

#Zika #Virus #Research #References #Library–October 15 2018 #Update, Issue No. 138

          

Title:

#Zika #Virus #Research #References #Library–October 15 2018 #Update, Issue No. 138.

Subject:

Zika Virus Infection and related complications research, weekly references library update.

Source:

AMEDEO, homepage: http://www.amedeo.com

Code:

[  R  ]

___

1

__

This Issue:

__

  1. BASTOS MM, Coelho FC.
    • Estimating under-observation and the full size of the 2016 Zika epidemic in Rio de Janeiro.
      • PLoS One. 2018;13:e0205001.
  2. JOOB B, Wiwanitkit V.
    • In utero Zika virus exposure and schizophrenia.
      • World J Biol Psychiatry. 2018 Oct 12:1-2. doi: 10.1080/15622975.2018.1533995.
  3. SULTAN N, Bukhari SA, Ali I, Asif M, et al.
    • Zika Virus: A Critical Analysis and Pharmaceutical Perspectives.
      • Crit Rev Eukaryot Gene Expr. 2018;28:357-371.
  4. LEE HJ, Cho Y, Kang HJ, Choi H, et al.
    • Identification of peptide based B-cell epitopes in Zika virus NS1.
      • Biochem Biophys Res Commun. 2018 Oct 8. pii: S0006-291X(18)32166.
  5. XIE X, Kum DB, Xia H, Luo H, et al.
    • A Single-Dose Live-Attenuated Zika Virus Vaccine with Controlled Infection Rounds that Protects against Vertical Transmission.
      • Cell Host Microbe. 2018;24:487-499.
  6. SACCHETTO L, Zauli DAG, Costa GB, Guagliardo SAJ, et al.
    • Screening for Zika virus RNA in sera of suspected cases: a retrospective cross-sectional study.
      • Virol J. 2018;15:155.
  7. GOODFELLOW FT, Willard KA, Wu X, Scoville S, et al.
    • Strain-Dependent Consequences of Zika Virus Infection and Differential Impact on Neural Development.
      • Viruses. 2018;10.
  8. CAVALCANTI AFC, Aguiar YPC, de Oliveira Melo AS, de Freitas Leal JIB, et al.
    • Teething symptoms in children with congenital Zika syndrome: A 2-year follow-up.
      • Int J Paediatr Dent. 2018 Oct 9. doi: 10.1111/ipd.12431.
  9. ESTOFOLETE CF, Terzian ACB, Colombo TE, de Freitas Guimaraes G, et al.
    • Co-infection between Zika and different Dengue serotypes during DENV outbreak in Brazil.
      • J Infect Public Health. 2018 Oct 6. pii: S1876-0341(18)30147.
  10. DIDERICHSEN F, Augusto LGDS, Perez B.
    • Understanding social inequalities in Zika infection and its consequences: A model of pathways and policy entry-points.
      • Glob Public Health. 2018 Oct 9:1-9. doi: 10.1080/17441692.2018.1532528.
  11. MARQUEZ-JURADO S, Nogales A, Avila-Perez G, Iborra FJ, et al.
    • An Alanine-to-Valine Substitution in the Residue 175 of Zika Virus NS2A Protein Affects Viral RNA Synthesis and Attenuates the Virus In Vivo.
      • Viruses. 2018;10.
  12. MANCERA-PAEZ O, Roman GC, Pardo-Turriago R, Rodriguez Y, et al.
    • Concurrent Guillain-Barre syndrome, transverse myelitis and encephalitis post-Zika: A case report and review of the pathogenic role of multiple arboviral immunity.
      • J Neurol Sci. 2018;395:47-53.
  13. ZHU G, Pan A, Gruber G, Lu L, et al.
    • Conformational States of Zika Virus Non-Structural Protein 3 Determined by Molecular Dynamics Simulations with Small-Angle X-Ray Scattering Data.
      • Prog Biophys Mol Biol. 2018 Oct 3. pii: S0079-6107(18)30063.
  14. O'REILLY KM, Lowe R, Edmunds WJ, Mayaud P, et al.
    • Projecting the end of the Zika virus epidemic in Latin America: a modelling analysis.
      • BMC Med. 2018;16:180.
  15. SETOH YX, Peng NY, Nakayama E, Amarilla AA, et al.
    • Fetal Brain Infection Is Not a Unique Characteristic of Brazilian Zika Viruses.
      • Viruses. 2018;10.
  16. BLITVICH BJ, Brault AC.
    • Chikungunya and Zika Viruses: Global Emerging Health Threats.
      • Am J Trop Med Hyg. 2018;99:1105-1106.
  17. HARSH S, Ozakman Y, Kitchen SM, Paquin-Proulx D, et al.
    • Dicer-2 Regulates Resistance and Maintains Homeostasis against Zika Virus Infection in Drosophila.
      • J Immunol. 2018 Oct 10. pii: jimmunol.1800597. doi: 10.4049/jimmunol.1800597.
  18. CHEN LH, Hamer DH.
    • Zika virus and sexual transmission: updated preconception guidance.
      • J Travel Med. 2018 Oct 5. pii: 5116055. doi: 10.1093.
  19. MACHADO-DUQUE ME, Machado-Alba JE, Rodriguez-Morales AJ.
    • Are the 2014-2016 Zika and Chikungunya epidemics in Colombia associated with a higher use of antihistamines?
      • Travel Med Infect Dis. 2018 Oct 3. pii: S1477-8939(18)30334.

-

Keywords: Zika Virus; Zika References Library; Research; Abstracts.

------

14 Oct 2018

#Cholera #Outbreak in #Yemen, 11 October 2018 #Update (@WHO EMRO, Oct. 14 ‘18)

          

Title:

#Cholera #Outbreak in #Yemen, 11 October 2018 #Update.

Subject:

Acute Watery Diarrhea, Cholera Outbreak in Yemen, update.

Source:

World Health Organization (WHO), Regional Office for the Eastern Mediterranean, full page: (LINK).

Code:

[     ]

___

1

__

14 October 2018


The Ministry of Public Health and Population of Yemen has reported 15201 suspected cases and 37 associated deaths during epidemiological week 38 (17 September – 23 September) in 2018. 14% are severe cases.

The cumulative total number of suspected cholera cases from 27 April 2017 to 23 September 2018 is 1,207,596 and 2510 associated deaths (CFR 0.21%). So far, 2980 samples have been confirmed by culture.

Children under 5 years of age represent 30.5% of the total suspected cases. So far, the cholera outbreak has affected 22 out of 23 governorates and 306 out of 333 districts in Yemen.

This week, the governorates reporting the highest number of suspected cases are Amran (2542), Al Hudaydah (2459), Dhamar (1965), Sana’a (1942) and Amanat Al Asimah (1611). At the country level, there has been an upward trend for 15 consecutive weeks and from week 35 to week 37 the trend of suspected cases is increasing by 16%. Eight governorates are presenting an increase of suspected cases which include Aden (+65%), Amran (+45%), Al Hudaydah (+27%) and  Taizz (+22%).

WHO, in coordination with Health and WASH cluster partners, continues to support the Ministry of Public Health and Population of Yemen to contain this outbreak through the strengthening of disease surveillance including laboratory capacity, case management and improving sanitation.

To date, out of 7321 samples collected during 2018, 1875 cases have been confirmed as cholera positive by culture at the central public health laboratories in Al Hudaydahm Sana’a, Taizz, and Aden governorates. The last positive culture was confirmed on 29 June 2018 in Amanat Al Asimah.

WHO has established an Oral rehydration corners (ORCs) at the health unit in Al Tawilha district, Al Mahwit governorate. Also WHO continues to support enhancing distribution of medication for cholera cases and conducting heatlh education to increase awareness among the vulnerable population. Currently Health Cluster partners operating 247 ORCs and 90 diarrhea treatment center (DTCs) in 98 districts 14 governorates in the country.

WHO and UNICEF, with MOPHP are preparing to conduct the second round of the oral cholera vaccination (OCV) campaign at the end of September in the northern governorates.

-

Keywords: WHO; Updates; Cholera; Yemen.

------

#Influenza and other #Respiratory #Viruses #Research #References #Library – October 14 2018 Issue

          

Title:

#Influenza and other #Respiratory #Viruses #Research #References #Library – October 14 2018 Issue.

Subject:

Human and Animal Influenza Viruses, other respiratory pathogens research, weekly references library update.

Source:

AMEDEO, homepage: http://www.amedeo.com

Code:

[  R  ]

___

1

__

This Issue:

__

  1. WU H, Yang F, Liu F, Peng X, et al.
    • Molecular characterization of H10 subtype avian influenza viruses isolated from poultry in Eastern China.
      • Arch Virol. 2018 Oct 9. pii: 10.1007/s00705-018-4019.
  2. LEE MS, Jang EY, Cho J, Kim K, et al.
    • Development and comparison of two H5N8 influenza A vaccine candidate strains.
      • Arch Virol. 2018 Oct 5. pii: 10.1007/s00705-018-4062.
  3. TANG Z, Zang N, Fu Y, Ye Z, et al.
    • HMGB1 mediates HAdV-7 infection-induced pulmonary inflammation in mice.
      • Biochem Biophys Res Commun. 2018;501:1-8.
  4. SUN X, Belser JA, Pappas C, Pulit-Penaloza JA, et al.
    • Risk assessment of fifth-wave H7N9 influenza A viruses in mammalian models.
      • J Virol. 2018 Oct 10. pii: JVI.01740-18. doi: 10.1128/JVI.01740.
  5. TOME-AMAT J, Ramos I, Amanor F, Fernandez-Sesma A, et al.
    • Influenza A virus utilizes low affinity, high avidity interactions with the nuclear import machinery to ensure infection and immune evasion.
      • J Virol. 2018 Oct 10. pii: JVI.01046-18. doi: 10.1128/JVI.01046.
  6. CHANG P, Sealy JE, Sadeyen JR, Iqbal M, et al.
    • Amino acid residue 217 in the hemagglutinin glycoprotein is a key mediator of avian influenza H7N9 virus antigenicity.
      • J Virol. 2018 Oct 3. pii: JVI.01627-18. doi: 10.1128/JVI.01627.
  7. JANG Y, Shin JS, Yoon YS, Go YY, et al.
    • Salinomycin Inhibits Influenza Virus Infection by Disrupting Endosomal Acidification and Viral Matrix Protein 2 Function.
      • J Virol. 2018 Oct 3. pii: JVI.01441-18. doi: 10.1128/JVI.01441.
  8. FAY EJ, Aron SL, Stone IA, Waring BM, et al.
    • Engineered small molecule control of influenza A virus replication.
      • J Virol. 2018 Oct 3. pii: JVI.01677-18. doi: 10.1128/JVI.01677.
  9. TSUZUKI S, Schwehm M, Eichner M.
    • Corrigendum to "Simulation studies to assess the long-term effects of Japan's change from trivalent to quadrivalent influenza vaccination" [Vaccine 36 (2018) 624-630].
      • Vaccine. 2018 Oct 3. pii: S0264-410X(18)31315.
  10. ROBISON SG, Thomas AR.
    • Assessing the effectiveness of high-dose influenza vaccine in preventing hospitalization among seniors, and observations on the limitations of effectiveness study design.
      • Vaccine. 2018 Oct 1. pii: S0264-410X(18)31319.
  11. MARCHENKO V, Goncharova N, Susloparov I, Kolosova N, et al.
    • Isolation and characterization of H5Nx highly pathogenic avian influenza viruses of clade 2.3.4.4 in Russia.
      • Virology. 2018;525:216-223.
  12. NARKPUK J, Jongkaewwattana A, Teeravechyan S.
    • The avian influenza virus PA segment mediates strain-specific antagonism of BST-2/tetherin.
      • Virology. 2018;525:161-169.

-

Keywords: Research; Abstracts; Influenza References Library.

------